Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
BMY
Bristol Myers Squibb
47
Follow
47
BMY
Bristol Myers Squibb
47
Follow
47
Likes Subject
Older
BMY 1Q23 results… DewDiligence 04/27/23 7:56 AM
Repotrectinib NDA has 11/27/23 PDUFA date—(with FDA priority review): DewDiligence 05/30/23 10:51 AM
CHMP approves Opdivo/chemo in neoadjuvant NSCLC: DewDiligence 05/26/23 2:31 PM
Milvexian—>FDA Fast Track designation for_all_indications: DewDiligence 05/25/23 8:38 AM
BMY’s BMS-986278 for IPF will advance to phase-3: DewDiligence 05/22/23 2:17 PM
IMMP +65% on interim (single-arm) phase-2 data for DewDiligence 05/17/23 4:58 PM
BMY’s ASCO/EHA/ICML lineup: DewDiligence 05/11/23 4:23 PM
$3.4M insider sale yesterday by BMY’s CSO, Rupert Vessey: DewDiligence 05/04/23 6:08 PM
BMY 1Q23 CC transcript: DewDiligence 04/28/23 9:04 AM
BMY 1Q23 results… DewDiligence 04/27/23 7:56 AM
BMY’s CCO, Christopher Boerner—>CEO effective 11/1/23: DewDiligence 04/26/23 4:43 PM
CHMP approves Camzyos: DewDiligence 04/26/23 3:39 PM
CHMP approves Breyanzi in second-line LBCL: DewDiligence 03/31/23 11:35 AM
BMY, EVO extend/expand neurodegeneration collaboration: DewDiligence 03/28/23 1:39 PM
EC approves Sotyktu for psoriasis: DewDiligence 03/28/23 10:17 AM
TAK-279 vs Sotyktu (from biopharmadive.com): #msg-171480207. DewDiligence 03/18/23 4:39 PM
BMY will not launch Opdualag in Germany due DewDiligence 03/07/23 5:05 PM
BMY/JNJ unveil_phase-3_program_for Milvexian—50,000 patients_across_three_ trial DewDiligence 03/02/23 8:41 AM
Opdivo PDUFA date for adjuvant melanoma—>10/13/23: DewDiligence 02/28/23 11:16 AM
BMY’s ACC lineup: DewDiligence 02/27/23 12:09 PM
BMY/TVST report Abecma data from phase-3 KarMMa-3 study: DewDiligence 02/10/23 3:40 PM
BMY -2.5% today—possible reason is that the CEO DewDiligence 02/09/23 3:06 PM
Bayer enrolls first phase-3 patients for FXIa inhibitor, Asundexian: DewDiligence 02/08/23 7:50 AM
BMY 4Q22 CC transcript: DewDiligence 02/02/23 4:11 PM
BMY’s Sotyktu patients are coming approximately 1/3 from DewDiligence 02/02/23 9:23 AM
BMY 4Q22 CC slides: DewDiligence 02/02/23 9:06 AM
BMY 4Q22 results—2023 guidance: DewDiligence 02/02/23 8:26 AM
CHMP approves BMY’s Sotyktu for psoriasis: DewDiligence 01/27/23 10:29 AM
Addendum—Breyanzi is the first CAR-T to show efficacy DewDiligence 01/26/23 7:54 PM
BMY’s Breyanzi meets primary endpoint in rrCLL/SLL single-arm trial: DewDiligence 01/26/23 10:45 AM
BMY’s JPM webcast slides: DewDiligence 01/09/23 10:40 AM
BMY’s Breyanzi continues to show robust results in DewDiligence 12/12/22 11:53 AM
BMY’s ASH presentations: DewDiligence 12/12/22 9:54 AM
BMY boosts annualized dividend to $2.28—(from $2.16): DewDiligence 12/08/22 5:38 PM
BMY’s ASH lineup: DewDiligence 11/21/22 9:44 AM
BMY’s AHA presentation lineup: DewDiligence 11/02/22 9:04 AM
BMY scores phase-3 win for Reblozyl in a DewDiligence 10/31/22 11:45 AM
BMY 3Q22 CC transcript: DewDiligence 10/26/22 4:36 PM
BMY 3Q22 CC slides: DewDiligence 10/26/22 7:59 AM
BMY 3Q22 results—2022 non-GAAP guidance unchanged: DewDiligence 10/25/22 7:48 PM
Camzyos sNDA for prevention of SRT* in patients DewDiligence 10/21/22 8:48 AM
BMY—Opdivo monotherapy—>RFS HR=0.42 in adjuvant melanoma: DewDiligence 10/19/22 5:09 PM
Opdivo monotherapy shows statsig RFS in adjuvant melanoma DewDiligence 09/15/22 10:20 AM
https://biopharma.media/deucravacitinib-miracle-drug-for-autoimmune-diseases-109 joe_techi 09/10/22 4:43 PM
What is the link for that? TIA DewDiligence 09/10/22 4:16 PM
Sotyktu: Miracle Pill for Autoimmune Diseases joe_techi 09/10/22 3:46 PM
Perfect timing—BMY reports 2yr Sotyktu data in psoriasis DewDiligence 09/10/22 2:53 PM
FDA approves Sotyktu (deucravacitinib) for psoriasis: DewDiligence 09/09/22 11:04 PM
BMY/JNJ—Milvexian phase-2 data in treatment of acute ischemic stroke… DewDiligence 08/28/22 2:16 PM
Opdivo/Yervoy misses DFS primary endpoint in adjuvant RCC: DewDiligence 07/29/22 2:07 PM
BMY 2Q22 CC transcript: DewDiligence 07/27/22 4:49 PM
Likes Subject
Older

Older
DewDiligence
04/27/23 7:56 AM
DewDiligence
05/30/23 10:51 AM
DewDiligence
05/26/23 2:31 PM
DewDiligence
05/25/23 8:38 AM
DewDiligence
05/22/23 2:17 PM
DewDiligence
05/17/23 4:58 PM
DewDiligence
05/11/23 4:23 PM
DewDiligence
05/04/23 6:08 PM
DewDiligence
04/28/23 9:04 AM
DewDiligence
04/27/23 7:56 AM
DewDiligence
04/26/23 4:43 PM
DewDiligence
04/26/23 3:39 PM
DewDiligence
03/31/23 11:35 AM
DewDiligence
03/28/23 1:39 PM
DewDiligence
03/28/23 10:17 AM
DewDiligence
03/18/23 4:39 PM
DewDiligence
03/07/23 5:05 PM
DewDiligence
03/02/23 8:41 AM
DewDiligence
02/28/23 11:16 AM
DewDiligence
02/27/23 12:09 PM
DewDiligence
02/10/23 3:40 PM
DewDiligence
02/09/23 3:06 PM
DewDiligence
02/08/23 7:50 AM
DewDiligence
02/02/23 4:11 PM
DewDiligence
02/02/23 9:23 AM
DewDiligence
02/02/23 9:06 AM
DewDiligence
02/02/23 8:26 AM
DewDiligence
01/27/23 10:29 AM
DewDiligence
01/26/23 7:54 PM
DewDiligence
01/26/23 10:45 AM
DewDiligence
01/09/23 10:40 AM
DewDiligence
12/12/22 11:53 AM
DewDiligence
12/12/22 9:54 AM
DewDiligence
12/08/22 5:38 PM
DewDiligence
11/21/22 9:44 AM
DewDiligence
11/02/22 9:04 AM
DewDiligence
10/31/22 11:45 AM
DewDiligence
10/26/22 4:36 PM
DewDiligence
10/26/22 7:59 AM
DewDiligence
10/25/22 7:48 PM
DewDiligence
10/21/22 8:48 AM
DewDiligence
10/19/22 5:09 PM
DewDiligence
09/15/22 10:20 AM
joe_techi
09/10/22 4:43 PM
DewDiligence
09/10/22 4:16 PM
joe_techi
09/10/22 3:46 PM
DewDiligence
09/10/22 2:53 PM
DewDiligence
09/09/22 11:04 PM
DewDiligence
08/28/22 2:16 PM
DewDiligence
07/29/22 2:07 PM
DewDiligence
07/27/22 4:49 PM

Bristol Myers Squibb (BMY)

Followers
47
Posters
112
Posts (Today)
0
Posts (Total)
1151
Created
01/04/07
Type
Free
Moderators DewDiligence
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
Upgrade to Real-Time
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Detailed Quote
BMY Latest News
More BMY News
Most Liked Posts
(Last 30 Days)
New Post